These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 1309218)
21. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings. Birnbaum BA; Weinreb JC; Fernandez MP; Brown JJ; Rofsky NM; Young SW Clin Imaging; 1994; 18(1):21-7. PubMed ID: 8180855 [TBL] [Abstract][Full Text] [Related]
22. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging. Coffin CM; Diche T; Mahfouz A; Alexandre M; Caseiro-Alves F; Rahmouni A; Vasile N; Mathieu D Eur Radiol; 1999; 9(3):444-9. PubMed ID: 10087113 [TBL] [Abstract][Full Text] [Related]
23. Mn-DPDP-enhanced MR imaging of malignant liver lesions: efficacy and safety in 20 patients. Aicher KP; Laniado M; Kopp AF; Grönewäller E; Duda SH; Claussen CD J Magn Reson Imaging; 1993; 3(5):731-7. PubMed ID: 8400558 [TBL] [Abstract][Full Text] [Related]
24. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging. Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572 [TBL] [Abstract][Full Text] [Related]
25. Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: preliminary results. Kettritz U; Schlund JF; Wilbur K; Eisenberg LB; Semelka RC Magn Reson Imaging; 1996; 14(10):1185-90. PubMed ID: 9065909 [TBL] [Abstract][Full Text] [Related]
26. Assessment of sequential enhancement patterns of focal nodular hyperplasia and hepatocellular carcinoma on mangafodipir trisodium enhanced MR imaging. Savellano DH; Köstler H; Baus S; Mössinger M; Gratz KF; Weimann A; Galanski M Invest Radiol; 2004 May; 39(5):305-12. PubMed ID: 15087726 [TBL] [Abstract][Full Text] [Related]
27. T2-weighted MR imaging in the assessment of cirrhotic liver. Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306 [TBL] [Abstract][Full Text] [Related]
28. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging. Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534 [TBL] [Abstract][Full Text] [Related]
29. A segmental hyperintensity area in the liver shown by delayed MR images with Mn-DPDP. Suto Y; Weinreb JC; Rofski NM J Comput Assist Tomogr; 1996; 20(4):647-9. PubMed ID: 8708073 [TBL] [Abstract][Full Text] [Related]
30. Characterization of liver lesions with mangafodipir trisodium-enhanced MR imaging: multicenter study comparing MR and dual-phase spiral CT. Oudkerk M; Torres CG; Song B; König M; Grimm J; Fernandez-Cuadrado J; Op de Beeck B; Marquardt M; van Dijk P; de Groot JC Radiology; 2002 May; 223(2):517-24. PubMed ID: 11997562 [TBL] [Abstract][Full Text] [Related]
31. Normal and infarcted myocardium: differentiation with cellular uptake of manganese at MR imaging in a rat model. Bremerich J; Saeed M; Arheden H; Higgins CB; Wendland MF Radiology; 2000 Aug; 216(2):524-30. PubMed ID: 10924581 [TBL] [Abstract][Full Text] [Related]
33. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging. Schima W; Saini S; Echeverri JA; Hahn PF; Harisinghani M; Mueller PR Radiology; 1997 Feb; 202(2):389-93. PubMed ID: 9015063 [TBL] [Abstract][Full Text] [Related]
34. Fast MR imaging of the liver: quantitative comparison of techniques. Siewert B; Müller MF; Foley M; Wielopolski PA; Finn JP Radiology; 1994 Oct; 193(1):37-42. PubMed ID: 8090918 [TBL] [Abstract][Full Text] [Related]
35. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051 [TBL] [Abstract][Full Text] [Related]
36. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images. Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248 [TBL] [Abstract][Full Text] [Related]
37. Enhancement of the normal pancreas: comparison of manganese-DPDP and gadolinium chelate. Kettritz U; Warshauer DM; Brown ED; Schlund JF; Eisenberg LB; Semelka RC Eur Radiol; 1996; 6(1):14-8. PubMed ID: 8797944 [TBL] [Abstract][Full Text] [Related]
38. Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs. Jung G; Heindel W; Krahe T; Kugel H; Walter C; Fischbach R; Klaus H; Lackner K Magn Reson Imaging; 1998 Oct; 16(8):925-31. PubMed ID: 9814775 [TBL] [Abstract][Full Text] [Related]